---
title: Colgate-Palmolive (CL) — intrinsic value and fair price
canonical: https://sweetvaluelab.com/stocks/cl
ticker: CL
as_of: 2026-10-17
sector: Consumer Defensive
industry: Household & Personal Products
---
# Colgate-Palmolive (CL)

Colgate-Palmolive (CL) closed at $94.11 on Oct 16, 2026, overvalued by 36% vs its model value of $69.43 (from a five-year discounted cash flow).

## Key figures

| Figure | Value |
| --- | ---: |
| Last close | $94.11 (Oct 16, 2026) |
| Model value (from a five-year discounted cash flow) | $69.43 |
| Price vs model | overvalued by 36% vs model |
| Range of that model | $38.26 – $193.00 |
| Market value | $75.0B |
| P/E (fiscal 2025) | 35.8 |
| Net margin (fiscal 2025) | 10.5% |
| Free cash flow (fiscal 2025) | $3.6B |
| Dividend yield (trailing twelve months) | 2.23% |
| Beta | 0.32 |
| Cost of capital (WACC) | 7.00% |
| Business classification | Mature & Stable (Low/slowing growth (~2% recent), Moderate margins (10% net margin), Highly cyclical earnings, High leverage (D/E 147.9x)) |

## On the stock lists

| List | Place | Figure | Page |
| --- | ---: | ---: | --- |
| Dividend growth streaks | #5 | 52+ years | https://sweetvaluelab.com/lists/dividend-growth-streaks |

## Dividends

| Figure | Value |
| --- | ---: |
| Trailing dividend yield | 2.23% |
| Dividends per share, last 12 months | $2.10 |
| Coverage | — |
| Raised | 52+ years in a row |
| Growth over 5 years | 3.4% a year |
| Latest payment | $0.53, ex-date Jul 20, 2026, paid Aug 14, 2026 |

| Year of payments | Dividends per share |
| --- | ---: |
| To Jul 20, 2021 | $1.78 |
| To Jul 20, 2022 | $1.84 |
| To Jul 20, 2023 | $1.90 |
| To Jul 19, 2024 | $1.96 |
| To Jul 18, 2025 | $2.04 |
| Trailing twelve months (to Jul 20, 2026) | $2.10 |

## Valuation models

Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026.

| Model | Role | Value per share | Low | High |
| --- | --- | ---: | ---: | ---: |
| DCF · Perpetuity growth · 5y | primary | $69.43 | $38.26 | $193.00 |
| DCF · Perpetuity growth · 10y | cross check | $70.69 | $40.52 | $191.52 |
| DCF · EBITDA exit · 5y | cross check | $55.13 | $34.63 | $79.40 |
| DCF · EBITDA exit · 10y | cross check | $58.57 | $37.67 | $86.73 |
| P/E · peers | cross check | $56.90 | $46.70 | $85.01 |
| P/E · own history | cross check | $104.33 | $90.80 | $113.07 |
| PEG | sanity check | $49.19 | $49.19 | $49.19 |
| EV/EBITDA · peers | cross check | $52.99 | $40.50 | $75.73 |
| EV/Revenue · peers | cross check | $50.02 | $39.19 | $81.08 |
| Earnings power value | cross check | $42.72 | $33.73 | $56.62 |
| Dividend discount | cross check | $51.97 | $32.59 | $105.63 |

## Insider activity (SEC Form 4)

No open-market insider buys or sales filed in the past 90 days.

| Date | Insider | Relationship | Transaction | Shares | Value |
| --- | --- | --- | --- | ---: | ---: |
| Oct 1, 2026 | NORRINGTON LORRIE M | Director | Grant / award | 300 | $26,226 |
| Oct 1, 2026 | Newman Brian | Director | Grant / award | 214 | $18,707.9 |
| Oct 1, 2026 | BILBREY JOHN P | Director | Grant / award | 271 | $23,690.8 |
| Sep 16, 2026 | Wallace Noel R. | Chairman, President & CEO | Grant / award | 205,197 | $0 |
| Sep 16, 2026 | Wallace Noel R. | Chairman, President & CEO | Grant / award | 29,649 | $0 |

## Recent SEC filings

| Filed | Form | What | Filing |
| --- | --- | --- | --- |
| Jul 31, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/21665/000002166526000042/cl-20260630.htm |
| Jul 31, 2026 | 8-K | 2.02 Results of Operations (Earnings); 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/21665/000002166526000041/cl-20260731.htm |
| May 13, 2026 | 8-K | 5.07 Submission of Matters to a Shareholder Vote | https://www.sec.gov/Archives/edgar/data/21665/000002166526000025/cl-20260508.htm |
| May 1, 2026 | 10-Q | Quarterly report | https://www.sec.gov/Archives/edgar/data/21665/000002166526000023/cl-20260331.htm |
| May 1, 2026 | 8-K | 2.02 Results of Operations (Earnings); 2.05 Costs of Exit or Disposal; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/21665/000002166526000022/cl-20260430.htm |

## Superinvestors holding it (latest 13F)

| Manager | Quarter | Shares | Value |
| --- | --- | ---: | ---: |
| First Eagle | 2026-06-30 | 8,205,699 | $752.3M |
| Yacktman | 2026-06-30 | 790,900 | $72.5M |
| Jensen | 2026-06-30 | 115,229 | $10.6M |
| Bridgewater | 2026-06-30 | 77,094 | $7.1M |

5 tracked managers in all.

## About

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmoliv…

---

Source: https://sweetvaluelab.com/stocks/cl (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.